蒋争凡发表论文
供稿：hz-xin.com 日期：2025-01-09
Huang YH, Liu XY, Du XX, Jiang Z, Su XD*. 2012, The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat Struct Mol Biol. 19(7):728-30.
Zhou X, You F, Chen H, Jiang Z*. 2012, Poly(C)-binding protein 1 mediates house-keeping degradation of mitochondrial antiviral signaling (MAVS). Cell Research. 22 (4): 717-727.
Chen H, Sun H, You F, Sun W, Zhou X, Chen L, Yang J, Wang Y, Tang H, Guan Y, Xia W, Gu J, Ishikawa H, Gutman D, Barber G, Qin Z, Jiang Z*. 2011, Activation of STAT6 by STING is Critical for Antiviral Innate Immunity. Cell. 147 (2): 436-446.
You FP, Sun H, Zhou X, Sun WX, Liang SM, Zhai ZH, Jiang Z*. 2009, PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nature Immunology.10: 1300-1308.
Sun W, Li Y, Chen L, Chen H, You F, Zhou X, Zhou Y, Zhai Z, Chen D, Jiang Z*. 2009, ERIS, an ER IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci USA. 106 (21): 8653-8.
Xiao H, Qian W, Staschke K, Qian Y, Cui G, Deng L, Ehsani M, Wang X, Qian YW, Chen ZJ, Gilmour R, Jiang Z*, Li X*. 2008, Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NFkB activation. J Biol Chem. 283(21):14654-64.
Jiang Z, Georgel P, Li C, Choe J, Crozat K, Rutschmann S, Du X, Bigby T, Mudd S, Sovath S, Wilson IA, Olson A, Beutler B. 2006, Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc Natl Acad Sci USA. 103 (29): 10961-66.
Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B. 2005, CD14 is required for MyD88-independent LPS signaling. Nature Immunology. 6(6): 565-70.
Jiang Z, Mak TW, Sen G, Li X. 2004, Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci USA. 101(10): 3533-8.
Jiang Z, Zamanian-Daryoush M, Nie H, Silva AM, Williams BR, Li X. 2003 Poly (IC)-induced TLR3-mediated activation of NFkappa B and MAP kinase is through an IRAK-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem. 278(19): 16713-9.
Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X. 2003, Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IRAK4-IRAK-TRAF6 complex. J Biol Chem. 278(13): 10952-6.
Jiang Z,Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X. 2002, Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol. 22(20): 7158-67.
Beutler B,Jiang Z,Georgel P, Crozat K, Croker B, Rutschmann S, Du X and Hoebe K, 2006, Genetic Analysis of Host Resistance: Toll-like Receptor Signaling and Immunity at Large. Annual Review of Immunology 24: 353-89.
Qian Y, Zhao Z,Jiang Z, Li X. 2002, Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc Natl Acad Sci USA. 99(14): 9386-91.
Li X, Commane M, Jiang Z, Stark GR. 2001, IL-1-induced NFkB and JNK activation diverge at IRAK. Proc Natl Acad Sci USA. 98(8): 4461-5.
Jiang Z, Hong X, Long H, Zhai ZH, 2000, Ceramides induce apoptosis in Hela cells and enhance cytochrome c-induced apoptosis in Xenopus egg extracts. Cell Mol Life Sci. 57(7): 1117-25.
Schabbauer G, Luyendyk J, Crozat K,Jiang Z, Mackman N, Bahram S, Georgel P. 2008, TLR4/CD14-mediated PI3K activation is an essential component of interferon -dependent VSV resistance in macrophages. Mol Immunol. 45(10):2790-6.
M. Otsuka, Q. Jing, P. Georgel, New, J. Chen, J. Mols, Y.J. Kang, Z. Jiang, S. C. Das, A. K. Pattnaik, J. Carlos dela Torre, B. Beutler and J. Han. 2007, Hypersusceptibility to vesicular stomatitis virus infection in Dicer-deficient mice is due to impaired miR24 and miR93 expression. Immunity, 27: 123-134.
Yao J, Kim TW, Qin J, Jiang Z, Qian Y, Xiao H, Lu Y, Qian W, Gulen MF, Sizemore N, DiDonato J, Sato S, Akira S, Su B, Li X. 2007, Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkB activation pathways bifurcate at IRAK modification. J Biol Chem. 282(9):6075-89.
Jin G, Klika A, Callahan M, Faga B, Danzig J, Jiang Z, Li X, Stark GR, Harrington J, Sherf B. 2004, Identification of a human NFkB-activating protein, TAB3. Proc Natl Acad Sci USA. 101(7): 2028-33.
Georgel P, Jiang Z, Kunz S, Janssen E, Mols J, Hoebe K, Bahram S, Oldstone MB, Beutler B. 2007, Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362(2): 304-313.
Huber M, Kalis C, Keck S, Jiang Z, Georgel P, et al. 2006, R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol. 36: 701-11.
Hoebe K.Jiang Z,George P, Tabeta K, Janssen E, Du X, and Beutler B. 2006, TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. Current Pharmaceutical Design 12: 4123-34.
Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B. 2005, A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun. 73: 4512-21.
Hoebe K, Jiang Z, Tabeta K, Du X, Georgel P, Crozat K, Beutler B. 2006, Genetic analysis of innate immunity. Adv immunol. 91: 175-226.
Beutler B, Georgel P, Rutschmann S, Jiang Z, Croker B, Crozat K. 2005, Genetic analysis of innate resistance to mouse cytomegalovirus (MCMV). Brief Funct Genomic Proteomic. 4:203-13. Review.
Zhou Z, Hoebe K, Du X, Jiang Z, Shamel L, Beutler B. 2005, Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation. Eur J Immunol. 35 (6): 1918-27.
Qin J, Jiang Z, Qian Y, Casanova JL, Li X. 2004, IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness. J Biol Chem. 279(25): 26748-53.
Silva AM, Whitmore M, Xu Z, Jiang Z, Li X, Williams BR. 2004, Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation. J Biol Chem. 279(36): 37670-6.
Nguyen H, Chatterjee-Kishore M, Jiang Z, Qing Y, Ramana CV, Bayes J, Commane M, Li X, Stark GR. 2003, IRAK-dependent phosphorylation of Stat1 on serine727 inresponse to IL-1 and effects on gene expression. J Interferon Cytokine Res. 23 (4): 183-92.
Zhou X, You F, Chen H, Jiang Z*. 2012, Poly(C)-binding protein 1 mediates house-keeping degradation of mitochondrial antiviral signaling (MAVS). Cell Research. 22 (4): 717-727.
Chen H, Sun H, You F, Sun W, Zhou X, Chen L, Yang J, Wang Y, Tang H, Guan Y, Xia W, Gu J, Ishikawa H, Gutman D, Barber G, Qin Z, Jiang Z*. 2011, Activation of STAT6 by STING is Critical for Antiviral Innate Immunity. Cell. 147 (2): 436-446.
You FP, Sun H, Zhou X, Sun WX, Liang SM, Zhai ZH, Jiang Z*. 2009, PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nature Immunology.10: 1300-1308.
Sun W, Li Y, Chen L, Chen H, You F, Zhou X, Zhou Y, Zhai Z, Chen D, Jiang Z*. 2009, ERIS, an ER IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci USA. 106 (21): 8653-8.
Xiao H, Qian W, Staschke K, Qian Y, Cui G, Deng L, Ehsani M, Wang X, Qian YW, Chen ZJ, Gilmour R, Jiang Z*, Li X*. 2008, Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NFkB activation. J Biol Chem. 283(21):14654-64.
Jiang Z, Georgel P, Li C, Choe J, Crozat K, Rutschmann S, Du X, Bigby T, Mudd S, Sovath S, Wilson IA, Olson A, Beutler B. 2006, Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc Natl Acad Sci USA. 103 (29): 10961-66.
Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B. 2005, CD14 is required for MyD88-independent LPS signaling. Nature Immunology. 6(6): 565-70.
Jiang Z, Mak TW, Sen G, Li X. 2004, Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci USA. 101(10): 3533-8.
Jiang Z, Zamanian-Daryoush M, Nie H, Silva AM, Williams BR, Li X. 2003 Poly (IC)-induced TLR3-mediated activation of NFkappa B and MAP kinase is through an IRAK-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem. 278(19): 16713-9.
Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X. 2003, Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IRAK4-IRAK-TRAF6 complex. J Biol Chem. 278(13): 10952-6.
Jiang Z,Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X. 2002, Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol. 22(20): 7158-67.
Beutler B,Jiang Z,Georgel P, Crozat K, Croker B, Rutschmann S, Du X and Hoebe K, 2006, Genetic Analysis of Host Resistance: Toll-like Receptor Signaling and Immunity at Large. Annual Review of Immunology 24: 353-89.
Qian Y, Zhao Z,Jiang Z, Li X. 2002, Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc Natl Acad Sci USA. 99(14): 9386-91.
Li X, Commane M, Jiang Z, Stark GR. 2001, IL-1-induced NFkB and JNK activation diverge at IRAK. Proc Natl Acad Sci USA. 98(8): 4461-5.
Jiang Z, Hong X, Long H, Zhai ZH, 2000, Ceramides induce apoptosis in Hela cells and enhance cytochrome c-induced apoptosis in Xenopus egg extracts. Cell Mol Life Sci. 57(7): 1117-25.
Schabbauer G, Luyendyk J, Crozat K,Jiang Z, Mackman N, Bahram S, Georgel P. 2008, TLR4/CD14-mediated PI3K activation is an essential component of interferon -dependent VSV resistance in macrophages. Mol Immunol. 45(10):2790-6.
M. Otsuka, Q. Jing, P. Georgel, New, J. Chen, J. Mols, Y.J. Kang, Z. Jiang, S. C. Das, A. K. Pattnaik, J. Carlos dela Torre, B. Beutler and J. Han. 2007, Hypersusceptibility to vesicular stomatitis virus infection in Dicer-deficient mice is due to impaired miR24 and miR93 expression. Immunity, 27: 123-134.
Yao J, Kim TW, Qin J, Jiang Z, Qian Y, Xiao H, Lu Y, Qian W, Gulen MF, Sizemore N, DiDonato J, Sato S, Akira S, Su B, Li X. 2007, Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkB activation pathways bifurcate at IRAK modification. J Biol Chem. 282(9):6075-89.
Jin G, Klika A, Callahan M, Faga B, Danzig J, Jiang Z, Li X, Stark GR, Harrington J, Sherf B. 2004, Identification of a human NFkB-activating protein, TAB3. Proc Natl Acad Sci USA. 101(7): 2028-33.
Georgel P, Jiang Z, Kunz S, Janssen E, Mols J, Hoebe K, Bahram S, Oldstone MB, Beutler B. 2007, Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362(2): 304-313.
Huber M, Kalis C, Keck S, Jiang Z, Georgel P, et al. 2006, R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol. 36: 701-11.
Hoebe K.Jiang Z,George P, Tabeta K, Janssen E, Du X, and Beutler B. 2006, TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. Current Pharmaceutical Design 12: 4123-34.
Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B. 2005, A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun. 73: 4512-21.
Hoebe K, Jiang Z, Tabeta K, Du X, Georgel P, Crozat K, Beutler B. 2006, Genetic analysis of innate immunity. Adv immunol. 91: 175-226.
Beutler B, Georgel P, Rutschmann S, Jiang Z, Croker B, Crozat K. 2005, Genetic analysis of innate resistance to mouse cytomegalovirus (MCMV). Brief Funct Genomic Proteomic. 4:203-13. Review.
Zhou Z, Hoebe K, Du X, Jiang Z, Shamel L, Beutler B. 2005, Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation. Eur J Immunol. 35 (6): 1918-27.
Qin J, Jiang Z, Qian Y, Casanova JL, Li X. 2004, IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness. J Biol Chem. 279(25): 26748-53.
Silva AM, Whitmore M, Xu Z, Jiang Z, Li X, Williams BR. 2004, Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation. J Biol Chem. 279(36): 37670-6.
Nguyen H, Chatterjee-Kishore M, Jiang Z, Qing Y, Ramana CV, Bayes J, Commane M, Li X, Stark GR. 2003, IRAK-dependent phosphorylation of Stat1 on serine727 inresponse to IL-1 and effects on gene expression. J Interferon Cytokine Res. 23 (4): 183-92.
高二关于奋斗的议论文
高二关于奋斗的议论文篇1 我们什么都没有,有一个本钱就是青春。梦想让我与众不同,奋斗让我改变命运!——题记 郭德纲说过:“我小时候家里穷,那时候在学校一下雨,别的孩子就站在教室里等伞,可我知道我家没伞啊,所以我就顶着雨往家跑,没伞的孩子你就得拼命奔跑!像我们这样没背景、没家境、没关系、没金钱的,...
弱者自强即可为强者议论文作文700字
弱者自强即可为强者议论文作文700字 篇1 天行健,君子以自强不息。挫折,这个词大家一定不陌生。挫折,对于人们来说,是绊脚石,是人生旅程中的障碍。“世界上的事情永远不是绝对的,结果完全因人而异。对于天才是一块垫脚石,对于能干的人是一笔财富,对于弱者是万丈深渊。”巴尔扎克说过。 挫折并不是的,在现实生活中,...
法律论文范文8000字
法律论文范文8000字篇1 浅析宪法在依法治国中的重要作用 论文摘要:依法治国就是依完治国。宪法是国家的根本大法,是治国安邦的总章程,规定了整个国家的基本制度和法律运行机制,公民的基本权利和自由,具有最高的法律效力。加强宪法的实施,必须改进全社会的宪法观念,加强宪法的宣传,宪法实施的监督,宪法的司法化等工作。
初二优秀议论文
初二优秀议论文1 已经记不起是哪位诗人曾经说过:“宝剑锋自磨砺出,梅花香自苦寒来。”我不敢说自己已经完全领悟了这其中的真谛,但是我敢说没有经历过痛苦和挫折的人是一定不会明白的。 也许,人在小的时候注定是要吮吸爱的乳汁,尝到幸福的甜蜜。然而,这不是真正的人生。也许,从我们摔的第一跤起,我们才知道有...
科技论文的格式和要求
被列入的论文参考文献应该只限于那些著者亲自阅读过和论文中引用过,而且正式发表的出版物,或其他有关档案资料,包括专利等文献。 特别提示 科技论文写作应注意的问题 1、对于初写科技论文的人来说,论文题目不宜太大,篇幅不宜太长,涉及问题的面不宜过宽,论述的问题也不求过深。应尽可能在前人已有知识的基础上...
论述“公开发表论文助你走向成功”
论述如下：“公开发表论文是对最新科技科学研究成果、研究方法的一种展示和报道。以推动整个社会的科技进步等。对个人影响如下：科研论文，不仅是反映科研成果的问题，而且也是个深化科研成果和发展科研成果的问题，在撰写科研论文过程中，对实验研究过程所取得的大量材料进行去粗取精，实现由感性认识向理性认识...
高中优秀议论文800字精选5篇
高中议论文800字1 生于世界上,存于宇宙间,我没有叱咤风云的雄伟气魄,没有武帝扬鞭东指的九死不悔,更没有司马迁成一家之言的宏功伟业,但我渴望陶渊明的怡然自得,渴望能有自己的一片天。 或许,我好像那个摔了跤的小孩,此时正经历炉火的冶炼,家庭,学校,社会的期盼,让我手足失措。虽然摔了一跤,然而我能够再重...
Sci第八作者有用吗
没有。其实无论是什么论文，凡是数位作者共同完成的文章，一定是排名越靠前越有用，排名比较靠后的基本什么作用都发挥不了了，SCI论文与国内论文不同，SCI论文通常涉及大量的数据文献和实验的开展，写作发表难度比较大，十几人共同完成也不罕见，这种情况需要特别注意作者的排名顺序，SCI论文人数一般没有...
如何投稿论文
10、有知名学者指导的论文一定要加以说明,或署名第2作者,这样发表的机会最大。 以上是本人总结的发表论文技巧,不提倡弄虚作假。望广大朋友讨论补充,使普通医务工作者论文能顺利发表。 论文投稿技巧(二)大多数报刊杂志都有相对稳定的作者群和稿源,要在激烈的用稿竞争中获胜,为自己争得一席之地,使自己的作品尽可能...
SCI论文发表被拒怎么办?
详细具体。各审稿人的问题和我们的回复要显著区分开。凡是缺点我们都要逐个改正，凡是夸奖，我们都要一一感谢。只要耐心花时间与审稿人认真讨论，坚持到最终，SCI论文总有见刊的机会，同时还与审稿者和主编建立了良好的关系，使得论文发表后得到了良好的国际引述。